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RENAL ALLOGRAFT rupture (RAR) is a rare butvery serious complication of renal transplantation,
requiring emergency surgery. The most common cause is
acute allograft rejection, but other causes such as renal vein
thrombosis (RVT), acute tubular necrosis (ATN), renal
biopsy, and lymphatic obstruction have been reported.1,2
We reviewed our experience with the aim of identifying
RAR predisposing conditions.
PATIENTS AND METHODS
In a consecutive series of 934 renal transplants performed between
July 1983 and September 1999, 11 patients (1.2%) had RAR. In
these cases we studied donor and recipient characteristics, preser-
vation conditions, clinical signs and symptoms, treatment, and
pathology findings. This group of patients was then compared with
their paired cohort. Data analysis was computer-based. In the
statistical analysis t test and Fisher’s exact test were used.
RESULTS
All 11 kidneys that suffered RAR were from cadaver
donors, nine male and two female. The mean age was 29.5
years with good terminal serum creatinine (mean 1.1 mg/
dL). All organs were stored in Eurocollins solution and the
mean cold ischemia time was 21 hours and 25 minutes
(range, 10 hours to 29 hours and 20 minutes).
Excluding one black patient, all recipients were Cauca-
sian. Eight were female and 3 were male, with a mean age
of 33.8 years. The mean HLA match was 1.7, and the mean
peak panel reactive antibody (PRA) was 22% (range 0 to
93%) and current was 15% (range 0 to 67%). All patients
had cyclosporine treatment, eight had delayed graft func-
tion requiring dialysis, and three underwent renal allograft
biopsy. In two patients rupture occurred in the second
allograft; the others were first transplants.
The day of RAR was a mean of 5.3 (range 2 to 13). All
patients had new onset of severe allograft pain, eight had a
drop in daily hematocrit, and six had hypotension. The four
patients with more precocious ruptures had sudden onset of
bleeding through the drainage tube.
Transplant nephrectomy was performed in 10 patients,
and surgical conservative treatment with fibrin glue and
collagen foam was performed in one. All patients survived
RAR. Three had a second transplant and currently have
functioning allografts.
Pathology examination revealed RVT in three patients
and some degree of rejection in the remaining eight. One
patient had a rupture on the second day because of
hyperacute rejection, and three had severe acute cellular
rejection, but in four patients the dominant figure was ATN
with minimal rejection. Excluding the patient with hyper-
acute rejection, the day of rupture was later for those with
severe acute rejection, a mean of 9.6 days (range 6 to 13). In
those with ATN, the day of RAR was a mean of 4.5 (range
3 to 6) and the patients with RVT had ruptures even
sooner, on mean third day (range 2 to 4).
Variables associated with RAR were: sex mismatch
(P 5 .004), current PRA (P 5 .012), and a need for
dialysis (P 5 .042). Age of the recipient, transplant
number, cold ischemia time, total HLA match, and peak
PRA were not associated with RAR.
DISCUSSION
Higher current PRA and a need for dialysis are variables
associated with rejection and ATN. Therefore they are
expected to be related to rupture. The well-documented
conditions that are associated with ATN and rejection3
must be the same, which in extreme conditions predispose
to RAR. We find no explanation for the statistically signif-
icant association of sex mismatch and RAR, other than
random error.
Acute allograft rejection is the most frequent cause of
graft rupture in the literature (60 to 80%),3 but ATN has
received little note. In our series, ATN was responsible for
36% of the ruptures, as much as severe acute rejection.
ATN alone can cause RAR,4 because of interstitial edema
and rise in intrarenal pressure. But when associated with
rejection, it seems that these two conditions can act syner-
gistically to cause allograft rupture.
Our data suggests that rupture occurs later when caused
by rejection, rather than when RVT is responsible. To our
knowledge this finding had never been reported in world
literature. Perhaps the timing of RVT is related to technical
problems, such as twisting and kinking of the vein or intima
tear, although the thrombogenic effect of cyclosporine can
also have a role in this process.5
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All these patients were on cyclosporine therapy, which
may explain the small number of RAR caused by rejection
alone and the significant number of patients that had RVT
(27%). It appears that cyclosporine therapy is changing the
etiology of the graft rupture.6
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